KMPH Insider Trading Activity and SEC Form 4 Filings
KMPH insider trading summary
No open-market insider purchases or sales of Kempharm, Inc (KMPH) have been reported on SEC Form 4 in the past 12 months.
Latest KMPH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 13, 2023 | R. LaDuane Clifton | CFO, Secretary & Treasurer | Buy | $4K (610 @ $5.82) |
| Jan 13, 2023 | Richard W Pascoe | Chief Executive Officer | Buy | $52K (9,500 @ $5.44) |
| Jan 13, 2023 | R. LaDuane Clifton | CFO, Secretary & Treasurer | Buy | $140 (25 @ $5.58) |
| Sep 30, 2022 | R. LaDuane Clifton | CFO, Secretary & Treasurer | Buy | $4K (600 @ $5.98) |
| Sep 30, 2022 | R. LaDuane Clifton | CFO, Secretary & Treasurer | Buy | $2K (400 @ $5.98) |
| May 25, 2022 | Travis C Mickle | President & CEO | Buy | $4K (1,000 @ $4.38) |
| May 25, 2022 | Travis C Mickle | President & CEO | Buy | $9K (2,000 @ $4.36) |
| May 25, 2022 | David S Tierney | Director | Buy | $9K (2,000 @ $4.39) |
| May 25, 2022 | Travis C Mickle | President & CEO | Buy | $44K (10,000 @ $4.39) |
| May 20, 2022 | Tamara A Seymour | Director | Buy | $974 (200 @ $4.87) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.